Xcout Intel
BioOrbit
BioOrbit is a UK-based biotech startup headquartered in London. The company builds infrastructure for scalable pharmaceutical manufacturing in space, using protein crystallization to turn hospital treatments into self-injectable home medicines.
Subscribe to see BioOrbit’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioOrbit at a glance
BioOrbit is a biotechnology company headquartered in United Kingdom. Its most recent funding round, Seed, raised $13.2M in April 2026. Xcout tracks 1 named person at BioOrbit, including Katie King (CEO).
BioOrbit leadership
- Katie KingCEO
BioOrbit funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $13.2M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
BioOrbit competitors
A few of BioOrbit's closest competitors — see the full list of competitors and alternatives →
Aloft Biotechnologies is a biotechnology company that develops microgravity biomanufacturing technology for space and terrestrial applications. The company provides cell processing, microbial culture, and fluid management systems designed for medical innovation and drug manufacturing in Low Earth Orbit.
Neion Bio is a biotechnology company founded in 2024 that has developed an egg-based biomanufacturing platform called Raptor to produce lower-cost biological molecules and therapeutic proteins, including monoclonal antibodies, enzymes, fusion proteins, peptides, and cytokines.
Saku Biosciences is an early-stage life sciences company founded in 2024 to improve the economics of biomanufacturing. The firm develops high-performance host cell products designed to advance biological manufacturing processes and therapeutic production. It operates out of Los Angeles, California, with a small team of approximately 8 employees.
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
Helogen builds autonomous space factories, spacecraft, and orbital infrastructure to manufacture high-value biomaterials and advanced products in orbit for return to Earth. The company serves commercial and government customers in sectors such as regenerative medicine, orthopedics, and advanced industrial materials.
Constructive Bio is a biotechnology research company headquartered in Cambridge, United Kingdom, that focuses on designing and manufacturing proteins with non-canonical amino acids for new medicines and materials.
Get BioOrbit's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BioOrbit in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access